nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefaclor—MPO—urinary bladder cancer	0.55	1	CbGaD
Cefaclor—MPO—Carboplatin—urinary bladder cancer	0.171	0.539	CbGbCtD
Cefaclor—MPO—Cisplatin—urinary bladder cancer	0.146	0.461	CbGbCtD
Cefaclor—SLC15A1—epithelium—urinary bladder cancer	0.000625	0.116	CbGeAlD
Cefaclor—SLC15A1—renal system—urinary bladder cancer	0.000579	0.108	CbGeAlD
Cefaclor—MPO—epithelium—urinary bladder cancer	0.000562	0.105	CbGeAlD
Cefaclor—SLC15A2—prostate gland—urinary bladder cancer	0.000531	0.0989	CbGeAlD
Cefaclor—MPO—renal system—urinary bladder cancer	0.000521	0.0971	CbGeAlD
Cefaclor—SLC15A2—seminal vesicle—urinary bladder cancer	0.00045	0.0837	CbGeAlD
Cefaclor—SLC15A1—vagina—urinary bladder cancer	0.00042	0.0781	CbGeAlD
Cefaclor—SLC15A2—renal system—urinary bladder cancer	0.000362	0.0674	CbGeAlD
Cefaclor—SLC15A2—urethra—urinary bladder cancer	0.000356	0.0662	CbGeAlD
Cefaclor—SLC15A2—female reproductive system—urinary bladder cancer	0.00029	0.054	CbGeAlD
Cefaclor—SLC15A2—vagina—urinary bladder cancer	0.000262	0.0488	CbGeAlD
Cefaclor—MPO—lymph node—urinary bladder cancer	0.000244	0.0455	CbGeAlD
Cefaclor—SLC15A2—lymph node—urinary bladder cancer	0.00017	0.0316	CbGeAlD
Cefaclor—Epistaxis—Methotrexate—urinary bladder cancer	0.000108	0.000854	CcSEcCtD
Cefaclor—Vomiting—Thiotepa—urinary bladder cancer	0.000108	0.000853	CcSEcCtD
Cefaclor—Infestation NOS—Epirubicin—urinary bladder cancer	0.000107	0.000847	CcSEcCtD
Cefaclor—Infestation—Epirubicin—urinary bladder cancer	0.000107	0.000847	CcSEcCtD
Cefaclor—Rash—Thiotepa—urinary bladder cancer	0.000107	0.000846	CcSEcCtD
Cefaclor—Dermatitis—Thiotepa—urinary bladder cancer	0.000107	0.000846	CcSEcCtD
Cefaclor—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000107	0.000845	CcSEcCtD
Cefaclor—Headache—Thiotepa—urinary bladder cancer	0.000106	0.000841	CcSEcCtD
Cefaclor—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000106	0.00084	CcSEcCtD
Cefaclor—Decreased appetite—Etoposide—urinary bladder cancer	0.000106	0.000838	CcSEcCtD
Cefaclor—Pancytopenia—Doxorubicin—urinary bladder cancer	0.000106	0.000835	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000105	0.000832	CcSEcCtD
Cefaclor—Body temperature increased—Cisplatin—urinary bladder cancer	0.000105	0.000832	CcSEcCtD
Cefaclor—Pain—Etoposide—urinary bladder cancer	0.000104	0.000825	CcSEcCtD
Cefaclor—Constipation—Etoposide—urinary bladder cancer	0.000104	0.000825	CcSEcCtD
Cefaclor—Conjunctivitis—Epirubicin—urinary bladder cancer	0.000104	0.000824	CcSEcCtD
Cefaclor—Dysuria—Doxorubicin—urinary bladder cancer	0.000104	0.000822	CcSEcCtD
Cefaclor—Neutropenia—Doxorubicin—urinary bladder cancer	0.000104	0.000822	CcSEcCtD
Cefaclor—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000104	0.000818	CcSEcCtD
Cefaclor—Haemoglobin—Methotrexate—urinary bladder cancer	0.000103	0.000817	CcSEcCtD
Cefaclor—Haemorrhage—Methotrexate—urinary bladder cancer	0.000103	0.000813	CcSEcCtD
Cefaclor—Hepatitis—Methotrexate—urinary bladder cancer	0.000103	0.000813	CcSEcCtD
Cefaclor—Sweating—Epirubicin—urinary bladder cancer	0.000103	0.000812	CcSEcCtD
Cefaclor—Asthenia—Gemcitabine—urinary bladder cancer	0.000103	0.00081	CcSEcCtD
Cefaclor—Haematuria—Epirubicin—urinary bladder cancer	0.000102	0.000808	CcSEcCtD
Cefaclor—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000102	0.000803	CcSEcCtD
Cefaclor—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000101	0.000801	CcSEcCtD
Cefaclor—Epistaxis—Epirubicin—urinary bladder cancer	0.000101	0.000799	CcSEcCtD
Cefaclor—Pruritus—Gemcitabine—urinary bladder cancer	0.000101	0.000799	CcSEcCtD
Cefaclor—Nausea—Thiotepa—urinary bladder cancer	0.000101	0.000797	CcSEcCtD
Cefaclor—Urethral disorder—Methotrexate—urinary bladder cancer	0.000101	0.000797	CcSEcCtD
Cefaclor—Sinusitis—Epirubicin—urinary bladder cancer	0.000101	0.000795	CcSEcCtD
Cefaclor—Feeling abnormal—Etoposide—urinary bladder cancer	0.000101	0.000795	CcSEcCtD
Cefaclor—Agranulocytosis—Epirubicin—urinary bladder cancer	0.0001	0.000791	CcSEcCtD
Cefaclor—Gastrointestinal pain—Etoposide—urinary bladder cancer	9.98e-05	0.000788	CcSEcCtD
Cefaclor—Pruritus—Fluorouracil—urinary bladder cancer	9.95e-05	0.000785	CcSEcCtD
Cefaclor—Infestation NOS—Doxorubicin—urinary bladder cancer	9.93e-05	0.000784	CcSEcCtD
Cefaclor—Infestation—Doxorubicin—urinary bladder cancer	9.93e-05	0.000784	CcSEcCtD
Cefaclor—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	9.84e-05	0.000777	CcSEcCtD
Cefaclor—Hypersensitivity—Cisplatin—urinary bladder cancer	9.82e-05	0.000775	CcSEcCtD
Cefaclor—Diarrhoea—Gemcitabine—urinary bladder cancer	9.78e-05	0.000773	CcSEcCtD
Cefaclor—Erythema multiforme—Methotrexate—urinary bladder cancer	9.73e-05	0.000769	CcSEcCtD
Cefaclor—Urticaria—Etoposide—urinary bladder cancer	9.7e-05	0.000766	CcSEcCtD
Cefaclor—Haemoglobin—Epirubicin—urinary bladder cancer	9.68e-05	0.000765	CcSEcCtD
Cefaclor—Rhinitis—Epirubicin—urinary bladder cancer	9.66e-05	0.000763	CcSEcCtD
Cefaclor—Abdominal pain—Etoposide—urinary bladder cancer	9.65e-05	0.000762	CcSEcCtD
Cefaclor—Body temperature increased—Etoposide—urinary bladder cancer	9.65e-05	0.000762	CcSEcCtD
Cefaclor—Conjunctivitis—Doxorubicin—urinary bladder cancer	9.65e-05	0.000762	CcSEcCtD
Cefaclor—Haemorrhage—Epirubicin—urinary bladder cancer	9.63e-05	0.000761	CcSEcCtD
Cefaclor—Hepatitis—Epirubicin—urinary bladder cancer	9.63e-05	0.000761	CcSEcCtD
Cefaclor—Diarrhoea—Fluorouracil—urinary bladder cancer	9.62e-05	0.00076	CcSEcCtD
Cefaclor—Asthenia—Cisplatin—urinary bladder cancer	9.56e-05	0.000755	CcSEcCtD
Cefaclor—Sweating—Doxorubicin—urinary bladder cancer	9.52e-05	0.000752	CcSEcCtD
Cefaclor—Urinary tract disorder—Epirubicin—urinary bladder cancer	9.51e-05	0.000751	CcSEcCtD
Cefaclor—Oedema peripheral—Epirubicin—urinary bladder cancer	9.49e-05	0.000749	CcSEcCtD
Cefaclor—Haematuria—Doxorubicin—urinary bladder cancer	9.47e-05	0.000748	CcSEcCtD
Cefaclor—Urethral disorder—Epirubicin—urinary bladder cancer	9.44e-05	0.000746	CcSEcCtD
Cefaclor—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	9.39e-05	0.000742	CcSEcCtD
Cefaclor—Epistaxis—Doxorubicin—urinary bladder cancer	9.37e-05	0.00074	CcSEcCtD
Cefaclor—Sinusitis—Doxorubicin—urinary bladder cancer	9.32e-05	0.000736	CcSEcCtD
Cefaclor—Immune system disorder—Methotrexate—urinary bladder cancer	9.3e-05	0.000734	CcSEcCtD
Cefaclor—Dizziness—Fluorouracil—urinary bladder cancer	9.3e-05	0.000734	CcSEcCtD
Cefaclor—Agranulocytosis—Doxorubicin—urinary bladder cancer	9.27e-05	0.000732	CcSEcCtD
Cefaclor—Chills—Methotrexate—urinary bladder cancer	9.24e-05	0.000729	CcSEcCtD
Cefaclor—Diarrhoea—Cisplatin—urinary bladder cancer	9.12e-05	0.00072	CcSEcCtD
Cefaclor—Erythema multiforme—Epirubicin—urinary bladder cancer	9.11e-05	0.000719	CcSEcCtD
Cefaclor—Vomiting—Gemcitabine—urinary bladder cancer	9.09e-05	0.000718	CcSEcCtD
Cefaclor—Rash—Gemcitabine—urinary bladder cancer	9.02e-05	0.000712	CcSEcCtD
Cefaclor—Dermatitis—Gemcitabine—urinary bladder cancer	9.01e-05	0.000711	CcSEcCtD
Cefaclor—Hypersensitivity—Etoposide—urinary bladder cancer	9e-05	0.00071	CcSEcCtD
Cefaclor—Haemoglobin—Doxorubicin—urinary bladder cancer	8.96e-05	0.000707	CcSEcCtD
Cefaclor—Headache—Gemcitabine—urinary bladder cancer	8.96e-05	0.000707	CcSEcCtD
Cefaclor—Vomiting—Fluorouracil—urinary bladder cancer	8.94e-05	0.000706	CcSEcCtD
Cefaclor—Rhinitis—Doxorubicin—urinary bladder cancer	8.94e-05	0.000706	CcSEcCtD
Cefaclor—Haemorrhage—Doxorubicin—urinary bladder cancer	8.91e-05	0.000704	CcSEcCtD
Cefaclor—Hepatitis—Doxorubicin—urinary bladder cancer	8.91e-05	0.000704	CcSEcCtD
Cefaclor—Rash—Fluorouracil—urinary bladder cancer	8.86e-05	0.0007	CcSEcCtD
Cefaclor—Dermatitis—Fluorouracil—urinary bladder cancer	8.86e-05	0.000699	CcSEcCtD
Cefaclor—Headache—Fluorouracil—urinary bladder cancer	8.81e-05	0.000695	CcSEcCtD
Cefaclor—Urinary tract disorder—Doxorubicin—urinary bladder cancer	8.8e-05	0.000695	CcSEcCtD
Cefaclor—Oedema peripheral—Doxorubicin—urinary bladder cancer	8.78e-05	0.000693	CcSEcCtD
Cefaclor—Asthenia—Etoposide—urinary bladder cancer	8.76e-05	0.000692	CcSEcCtD
Cefaclor—Urethral disorder—Doxorubicin—urinary bladder cancer	8.74e-05	0.00069	CcSEcCtD
Cefaclor—Immune system disorder—Epirubicin—urinary bladder cancer	8.7e-05	0.000687	CcSEcCtD
Cefaclor—Back pain—Methotrexate—urinary bladder cancer	8.67e-05	0.000684	CcSEcCtD
Cefaclor—Chills—Epirubicin—urinary bladder cancer	8.64e-05	0.000683	CcSEcCtD
Cefaclor—Pruritus—Etoposide—urinary bladder cancer	8.64e-05	0.000682	CcSEcCtD
Cefaclor—Nausea—Gemcitabine—urinary bladder cancer	8.49e-05	0.000671	CcSEcCtD
Cefaclor—Vomiting—Cisplatin—urinary bladder cancer	8.47e-05	0.000669	CcSEcCtD
Cefaclor—Erythema multiforme—Doxorubicin—urinary bladder cancer	8.43e-05	0.000666	CcSEcCtD
Cefaclor—Rash—Cisplatin—urinary bladder cancer	8.4e-05	0.000664	CcSEcCtD
Cefaclor—Dermatitis—Cisplatin—urinary bladder cancer	8.4e-05	0.000663	CcSEcCtD
Cefaclor—Diarrhoea—Etoposide—urinary bladder cancer	8.35e-05	0.00066	CcSEcCtD
Cefaclor—Nausea—Fluorouracil—urinary bladder cancer	8.35e-05	0.000659	CcSEcCtD
Cefaclor—Ill-defined disorder—Methotrexate—urinary bladder cancer	8.31e-05	0.000657	CcSEcCtD
Cefaclor—Flatulence—Epirubicin—urinary bladder cancer	8.26e-05	0.000653	CcSEcCtD
Cefaclor—Tension—Epirubicin—urinary bladder cancer	8.23e-05	0.00065	CcSEcCtD
Cefaclor—Nervousness—Epirubicin—urinary bladder cancer	8.14e-05	0.000643	CcSEcCtD
Cefaclor—Back pain—Epirubicin—urinary bladder cancer	8.11e-05	0.000641	CcSEcCtD
Cefaclor—Malaise—Methotrexate—urinary bladder cancer	8.08e-05	0.000638	CcSEcCtD
Cefaclor—Dizziness—Etoposide—urinary bladder cancer	8.07e-05	0.000638	CcSEcCtD
Cefaclor—Immune system disorder—Doxorubicin—urinary bladder cancer	8.05e-05	0.000636	CcSEcCtD
Cefaclor—Vertigo—Methotrexate—urinary bladder cancer	8.05e-05	0.000636	CcSEcCtD
Cefaclor—Leukopenia—Methotrexate—urinary bladder cancer	8.02e-05	0.000633	CcSEcCtD
Cefaclor—Chills—Doxorubicin—urinary bladder cancer	8e-05	0.000632	CcSEcCtD
Cefaclor—Nausea—Cisplatin—urinary bladder cancer	7.92e-05	0.000625	CcSEcCtD
Cefaclor—Cough—Methotrexate—urinary bladder cancer	7.82e-05	0.000618	CcSEcCtD
Cefaclor—Ill-defined disorder—Epirubicin—urinary bladder cancer	7.78e-05	0.000614	CcSEcCtD
Cefaclor—Convulsion—Methotrexate—urinary bladder cancer	7.76e-05	0.000613	CcSEcCtD
Cefaclor—Vomiting—Etoposide—urinary bladder cancer	7.76e-05	0.000613	CcSEcCtD
Cefaclor—Agitation—Epirubicin—urinary bladder cancer	7.71e-05	0.000609	CcSEcCtD
Cefaclor—Rash—Etoposide—urinary bladder cancer	7.7e-05	0.000608	CcSEcCtD
Cefaclor—Dermatitis—Etoposide—urinary bladder cancer	7.69e-05	0.000607	CcSEcCtD
Cefaclor—Headache—Etoposide—urinary bladder cancer	7.65e-05	0.000604	CcSEcCtD
Cefaclor—Flatulence—Doxorubicin—urinary bladder cancer	7.65e-05	0.000604	CcSEcCtD
Cefaclor—Myalgia—Methotrexate—urinary bladder cancer	7.63e-05	0.000602	CcSEcCtD
Cefaclor—Arthralgia—Methotrexate—urinary bladder cancer	7.63e-05	0.000602	CcSEcCtD
Cefaclor—Chest pain—Methotrexate—urinary bladder cancer	7.63e-05	0.000602	CcSEcCtD
Cefaclor—Tension—Doxorubicin—urinary bladder cancer	7.61e-05	0.000601	CcSEcCtD
Cefaclor—Malaise—Epirubicin—urinary bladder cancer	7.56e-05	0.000597	CcSEcCtD
Cefaclor—Discomfort—Methotrexate—urinary bladder cancer	7.54e-05	0.000595	CcSEcCtD
Cefaclor—Nervousness—Doxorubicin—urinary bladder cancer	7.54e-05	0.000595	CcSEcCtD
Cefaclor—Vertigo—Epirubicin—urinary bladder cancer	7.53e-05	0.000595	CcSEcCtD
Cefaclor—Syncope—Epirubicin—urinary bladder cancer	7.52e-05	0.000594	CcSEcCtD
Cefaclor—Leukopenia—Epirubicin—urinary bladder cancer	7.51e-05	0.000593	CcSEcCtD
Cefaclor—Back pain—Doxorubicin—urinary bladder cancer	7.51e-05	0.000593	CcSEcCtD
Cefaclor—Palpitations—Epirubicin—urinary bladder cancer	7.41e-05	0.000585	CcSEcCtD
Cefaclor—Confusional state—Methotrexate—urinary bladder cancer	7.37e-05	0.000582	CcSEcCtD
Cefaclor—Loss of consciousness—Epirubicin—urinary bladder cancer	7.37e-05	0.000582	CcSEcCtD
Cefaclor—Cough—Epirubicin—urinary bladder cancer	7.32e-05	0.000578	CcSEcCtD
Cefaclor—Anaphylactic shock—Methotrexate—urinary bladder cancer	7.31e-05	0.000578	CcSEcCtD
Cefaclor—Convulsion—Epirubicin—urinary bladder cancer	7.27e-05	0.000574	CcSEcCtD
Cefaclor—Nausea—Etoposide—urinary bladder cancer	7.25e-05	0.000573	CcSEcCtD
Cefaclor—Ill-defined disorder—Doxorubicin—urinary bladder cancer	7.2e-05	0.000569	CcSEcCtD
Cefaclor—Nervous system disorder—Methotrexate—urinary bladder cancer	7.17e-05	0.000566	CcSEcCtD
Cefaclor—Thrombocytopenia—Methotrexate—urinary bladder cancer	7.16e-05	0.000565	CcSEcCtD
Cefaclor—Chest pain—Epirubicin—urinary bladder cancer	7.14e-05	0.000564	CcSEcCtD
Cefaclor—Myalgia—Epirubicin—urinary bladder cancer	7.14e-05	0.000564	CcSEcCtD
Cefaclor—Arthralgia—Epirubicin—urinary bladder cancer	7.14e-05	0.000564	CcSEcCtD
Cefaclor—Agitation—Doxorubicin—urinary bladder cancer	7.13e-05	0.000563	CcSEcCtD
Cefaclor—Anxiety—Epirubicin—urinary bladder cancer	7.11e-05	0.000562	CcSEcCtD
Cefaclor—Hyperhidrosis—Methotrexate—urinary bladder cancer	7.07e-05	0.000558	CcSEcCtD
Cefaclor—Discomfort—Epirubicin—urinary bladder cancer	7.05e-05	0.000557	CcSEcCtD
Cefaclor—Malaise—Doxorubicin—urinary bladder cancer	7e-05	0.000553	CcSEcCtD
Cefaclor—Vertigo—Doxorubicin—urinary bladder cancer	6.97e-05	0.000551	CcSEcCtD
Cefaclor—Anorexia—Methotrexate—urinary bladder cancer	6.97e-05	0.000551	CcSEcCtD
Cefaclor—Syncope—Doxorubicin—urinary bladder cancer	6.96e-05	0.000549	CcSEcCtD
Cefaclor—Leukopenia—Doxorubicin—urinary bladder cancer	6.95e-05	0.000548	CcSEcCtD
Cefaclor—Confusional state—Epirubicin—urinary bladder cancer	6.9e-05	0.000545	CcSEcCtD
Cefaclor—Palpitations—Doxorubicin—urinary bladder cancer	6.86e-05	0.000541	CcSEcCtD
Cefaclor—Oedema—Epirubicin—urinary bladder cancer	6.84e-05	0.00054	CcSEcCtD
Cefaclor—Anaphylactic shock—Epirubicin—urinary bladder cancer	6.84e-05	0.00054	CcSEcCtD
Cefaclor—Hypotension—Methotrexate—urinary bladder cancer	6.83e-05	0.00054	CcSEcCtD
Cefaclor—Loss of consciousness—Doxorubicin—urinary bladder cancer	6.82e-05	0.000539	CcSEcCtD
Cefaclor—Cough—Doxorubicin—urinary bladder cancer	6.77e-05	0.000535	CcSEcCtD
Cefaclor—Shock—Epirubicin—urinary bladder cancer	6.73e-05	0.000532	CcSEcCtD
Cefaclor—Convulsion—Doxorubicin—urinary bladder cancer	6.72e-05	0.000531	CcSEcCtD
Cefaclor—Nervous system disorder—Epirubicin—urinary bladder cancer	6.71e-05	0.00053	CcSEcCtD
Cefaclor—Thrombocytopenia—Epirubicin—urinary bladder cancer	6.7e-05	0.000529	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	6.66e-05	0.000526	CcSEcCtD
Cefaclor—Hyperhidrosis—Epirubicin—urinary bladder cancer	6.62e-05	0.000522	CcSEcCtD
Cefaclor—Insomnia—Methotrexate—urinary bladder cancer	6.61e-05	0.000522	CcSEcCtD
Cefaclor—Arthralgia—Doxorubicin—urinary bladder cancer	6.61e-05	0.000522	CcSEcCtD
Cefaclor—Chest pain—Doxorubicin—urinary bladder cancer	6.61e-05	0.000522	CcSEcCtD
Cefaclor—Myalgia—Doxorubicin—urinary bladder cancer	6.61e-05	0.000522	CcSEcCtD
Cefaclor—Anxiety—Doxorubicin—urinary bladder cancer	6.58e-05	0.00052	CcSEcCtD
Cefaclor—Paraesthesia—Methotrexate—urinary bladder cancer	6.57e-05	0.000519	CcSEcCtD
Cefaclor—Discomfort—Doxorubicin—urinary bladder cancer	6.53e-05	0.000515	CcSEcCtD
Cefaclor—Anorexia—Epirubicin—urinary bladder cancer	6.52e-05	0.000515	CcSEcCtD
Cefaclor—Dyspnoea—Methotrexate—urinary bladder cancer	6.52e-05	0.000515	CcSEcCtD
Cefaclor—Somnolence—Methotrexate—urinary bladder cancer	6.5e-05	0.000513	CcSEcCtD
Cefaclor—Dyspepsia—Methotrexate—urinary bladder cancer	6.44e-05	0.000508	CcSEcCtD
Cefaclor—Hypotension—Epirubicin—urinary bladder cancer	6.4e-05	0.000505	CcSEcCtD
Cefaclor—Confusional state—Doxorubicin—urinary bladder cancer	6.39e-05	0.000504	CcSEcCtD
Cefaclor—Decreased appetite—Methotrexate—urinary bladder cancer	6.36e-05	0.000502	CcSEcCtD
Cefaclor—Oedema—Doxorubicin—urinary bladder cancer	6.33e-05	0.0005	CcSEcCtD
Cefaclor—Anaphylactic shock—Doxorubicin—urinary bladder cancer	6.33e-05	0.0005	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	6.31e-05	0.000499	CcSEcCtD
Cefaclor—Pain—Methotrexate—urinary bladder cancer	6.25e-05	0.000494	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	6.24e-05	0.000492	CcSEcCtD
Cefaclor—Shock—Doxorubicin—urinary bladder cancer	6.23e-05	0.000492	CcSEcCtD
Cefaclor—Nervous system disorder—Doxorubicin—urinary bladder cancer	6.21e-05	0.00049	CcSEcCtD
Cefaclor—Thrombocytopenia—Doxorubicin—urinary bladder cancer	6.2e-05	0.00049	CcSEcCtD
Cefaclor—Insomnia—Epirubicin—urinary bladder cancer	6.19e-05	0.000489	CcSEcCtD
Cefaclor—Paraesthesia—Epirubicin—urinary bladder cancer	6.15e-05	0.000485	CcSEcCtD
Cefaclor—Hyperhidrosis—Doxorubicin—urinary bladder cancer	6.12e-05	0.000483	CcSEcCtD
Cefaclor—Dyspnoea—Epirubicin—urinary bladder cancer	6.1e-05	0.000482	CcSEcCtD
Cefaclor—Somnolence—Epirubicin—urinary bladder cancer	6.08e-05	0.00048	CcSEcCtD
Cefaclor—Anorexia—Doxorubicin—urinary bladder cancer	6.04e-05	0.000477	CcSEcCtD
Cefaclor—Feeling abnormal—Methotrexate—urinary bladder cancer	6.03e-05	0.000476	CcSEcCtD
Cefaclor—Dyspepsia—Epirubicin—urinary bladder cancer	6.02e-05	0.000476	CcSEcCtD
Cefaclor—Gastrointestinal pain—Methotrexate—urinary bladder cancer	5.98e-05	0.000472	CcSEcCtD
Cefaclor—Decreased appetite—Epirubicin—urinary bladder cancer	5.95e-05	0.00047	CcSEcCtD
Cefaclor—Hypotension—Doxorubicin—urinary bladder cancer	5.92e-05	0.000467	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	5.91e-05	0.000467	CcSEcCtD
Cefaclor—Pain—Epirubicin—urinary bladder cancer	5.85e-05	0.000462	CcSEcCtD
Cefaclor—Constipation—Epirubicin—urinary bladder cancer	5.85e-05	0.000462	CcSEcCtD
Cefaclor—Urticaria—Methotrexate—urinary bladder cancer	5.81e-05	0.000459	CcSEcCtD
Cefaclor—Abdominal pain—Methotrexate—urinary bladder cancer	5.78e-05	0.000457	CcSEcCtD
Cefaclor—Body temperature increased—Methotrexate—urinary bladder cancer	5.78e-05	0.000457	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	5.77e-05	0.000456	CcSEcCtD
Cefaclor—Insomnia—Doxorubicin—urinary bladder cancer	5.73e-05	0.000452	CcSEcCtD
Cefaclor—Paraesthesia—Doxorubicin—urinary bladder cancer	5.69e-05	0.000449	CcSEcCtD
Cefaclor—Dyspnoea—Doxorubicin—urinary bladder cancer	5.65e-05	0.000446	CcSEcCtD
Cefaclor—Feeling abnormal—Epirubicin—urinary bladder cancer	5.64e-05	0.000445	CcSEcCtD
Cefaclor—Somnolence—Doxorubicin—urinary bladder cancer	5.63e-05	0.000445	CcSEcCtD
Cefaclor—Gastrointestinal pain—Epirubicin—urinary bladder cancer	5.6e-05	0.000442	CcSEcCtD
Cefaclor—Dyspepsia—Doxorubicin—urinary bladder cancer	5.57e-05	0.00044	CcSEcCtD
Cefaclor—Decreased appetite—Doxorubicin—urinary bladder cancer	5.5e-05	0.000435	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	5.47e-05	0.000432	CcSEcCtD
Cefaclor—Urticaria—Epirubicin—urinary bladder cancer	5.44e-05	0.000429	CcSEcCtD
Cefaclor—Constipation—Doxorubicin—urinary bladder cancer	5.42e-05	0.000428	CcSEcCtD
Cefaclor—Pain—Doxorubicin—urinary bladder cancer	5.42e-05	0.000428	CcSEcCtD
Cefaclor—Body temperature increased—Epirubicin—urinary bladder cancer	5.41e-05	0.000427	CcSEcCtD
Cefaclor—Abdominal pain—Epirubicin—urinary bladder cancer	5.41e-05	0.000427	CcSEcCtD
Cefaclor—Hypersensitivity—Methotrexate—urinary bladder cancer	5.39e-05	0.000426	CcSEcCtD
Cefaclor—Asthenia—Methotrexate—urinary bladder cancer	5.25e-05	0.000414	CcSEcCtD
Cefaclor—Feeling abnormal—Doxorubicin—urinary bladder cancer	5.22e-05	0.000412	CcSEcCtD
Cefaclor—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	5.18e-05	0.000409	CcSEcCtD
Cefaclor—Pruritus—Methotrexate—urinary bladder cancer	5.17e-05	0.000409	CcSEcCtD
Cefaclor—Hypersensitivity—Epirubicin—urinary bladder cancer	5.04e-05	0.000398	CcSEcCtD
Cefaclor—Urticaria—Doxorubicin—urinary bladder cancer	5.03e-05	0.000397	CcSEcCtD
Cefaclor—Abdominal pain—Doxorubicin—urinary bladder cancer	5.01e-05	0.000395	CcSEcCtD
Cefaclor—Body temperature increased—Doxorubicin—urinary bladder cancer	5.01e-05	0.000395	CcSEcCtD
Cefaclor—Diarrhoea—Methotrexate—urinary bladder cancer	5e-05	0.000395	CcSEcCtD
Cefaclor—Asthenia—Epirubicin—urinary bladder cancer	4.91e-05	0.000388	CcSEcCtD
Cefaclor—Pruritus—Epirubicin—urinary bladder cancer	4.84e-05	0.000382	CcSEcCtD
Cefaclor—Dizziness—Methotrexate—urinary bladder cancer	4.84e-05	0.000382	CcSEcCtD
Cefaclor—Diarrhoea—Epirubicin—urinary bladder cancer	4.68e-05	0.00037	CcSEcCtD
Cefaclor—Hypersensitivity—Doxorubicin—urinary bladder cancer	4.67e-05	0.000368	CcSEcCtD
Cefaclor—Vomiting—Methotrexate—urinary bladder cancer	4.65e-05	0.000367	CcSEcCtD
Cefaclor—Rash—Methotrexate—urinary bladder cancer	4.61e-05	0.000364	CcSEcCtD
Cefaclor—Dermatitis—Methotrexate—urinary bladder cancer	4.61e-05	0.000364	CcSEcCtD
Cefaclor—Headache—Methotrexate—urinary bladder cancer	4.58e-05	0.000362	CcSEcCtD
Cefaclor—Asthenia—Doxorubicin—urinary bladder cancer	4.54e-05	0.000359	CcSEcCtD
Cefaclor—Dizziness—Epirubicin—urinary bladder cancer	4.53e-05	0.000357	CcSEcCtD
Cefaclor—Pruritus—Doxorubicin—urinary bladder cancer	4.48e-05	0.000354	CcSEcCtD
Cefaclor—Vomiting—Epirubicin—urinary bladder cancer	4.35e-05	0.000344	CcSEcCtD
Cefaclor—Nausea—Methotrexate—urinary bladder cancer	4.34e-05	0.000343	CcSEcCtD
Cefaclor—Diarrhoea—Doxorubicin—urinary bladder cancer	4.33e-05	0.000342	CcSEcCtD
Cefaclor—Rash—Epirubicin—urinary bladder cancer	4.32e-05	0.000341	CcSEcCtD
Cefaclor—Dermatitis—Epirubicin—urinary bladder cancer	4.31e-05	0.00034	CcSEcCtD
Cefaclor—Headache—Epirubicin—urinary bladder cancer	4.29e-05	0.000339	CcSEcCtD
Cefaclor—Dizziness—Doxorubicin—urinary bladder cancer	4.19e-05	0.000331	CcSEcCtD
Cefaclor—Nausea—Epirubicin—urinary bladder cancer	4.07e-05	0.000321	CcSEcCtD
Cefaclor—Vomiting—Doxorubicin—urinary bladder cancer	4.03e-05	0.000318	CcSEcCtD
Cefaclor—Rash—Doxorubicin—urinary bladder cancer	3.99e-05	0.000315	CcSEcCtD
Cefaclor—Dermatitis—Doxorubicin—urinary bladder cancer	3.99e-05	0.000315	CcSEcCtD
Cefaclor—Headache—Doxorubicin—urinary bladder cancer	3.97e-05	0.000313	CcSEcCtD
Cefaclor—Nausea—Doxorubicin—urinary bladder cancer	3.76e-05	0.000297	CcSEcCtD
